<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cardiovasc Disord</journal-id><journal-id journal-id-type="iso-abbrev">BMC Cardiovasc Disord</journal-id><journal-title-group><journal-title>BMC Cardiovascular Disorders</journal-title></journal-title-group><issn pub-type="epub">1471-2261</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24252596</article-id><article-id pub-id-type="pmc">4225526</article-id><article-id pub-id-type="publisher-id">1471-2261-13-106</article-id><article-id pub-id-type="doi">10.1186/1471-2261-13-106</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Pedersen</surname><given-names>Lene R&#x000f8;rholm</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>lrpedersen@gmail.com</email></contrib><contrib contrib-type="author" equal-contrib="yes" id="A2"><name><surname>Olsen</surname><given-names>Rasmus Huan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>rasmus.huan.olsen@regionh.dk</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Frederiksen</surname><given-names>Marianne</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>marianne@hjertecafeen.dk</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Astrup</surname><given-names>Arne</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>ast@life.ku.dk</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Chabanova</surname><given-names>Elizaveta</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>Elizaveta.Chabanova@regionh.dk</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Hasbak</surname><given-names>Philip</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>Philip.Hasbak@regionh.dk</email></contrib><contrib contrib-type="author" id="A7"><name><surname>Holst</surname><given-names>Jens Juul</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>holst@mfi.ku.dk</email></contrib><contrib contrib-type="author" id="A8"><name><surname>Kj&#x000e6;r</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>akjaer@sund.ku.dk</email></contrib><contrib contrib-type="author" id="A9"><name><surname>Newman</surname><given-names>John W</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>John.Newman@ars.usda.gov</email></contrib><contrib contrib-type="author" id="A10"><name><surname>Walzem</surname><given-names>Rosemary</given-names></name><xref ref-type="aff" rid="I7">7</xref><email>rwalzem@poultry.tamu.edu</email></contrib><contrib contrib-type="author" id="A11"><name><surname>Wisl&#x000f8;ff</surname><given-names>Ulrik</given-names></name><xref ref-type="aff" rid="I8">8</xref><email>ulrik.wisloff@ntnu.no</email></contrib><contrib contrib-type="author" id="A12"><name><surname>Sajadieh</surname><given-names>Ahmad</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Ahmad.Sajadieh@regionh.dk</email></contrib><contrib contrib-type="author" id="A13"><name><surname>Haugaard</surname><given-names>Steen Bendix</given-names></name><xref ref-type="aff" rid="I9">9</xref><xref ref-type="aff" rid="I10">10</xref><email>sbhau@dadlnet.dk</email></contrib><contrib contrib-type="author" id="A14"><name><surname>Prescott</surname><given-names>Eva</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Eva.Irene.Bossano.Prescott@regionh.dk</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark</aff><aff id="I2"><label>2</label>Department of Nutrition, Exercise, and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark</aff><aff id="I3"><label>3</label>Department of Diagnostic Radiology, University Hospital of Herlev, Copenhagen, Denmark</aff><aff id="I4"><label>4</label>Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine &#x00026; PET, Copenhagen, Denmark</aff><aff id="I5"><label>5</label>Faculty of Health and Medical Sciences, Department of Biomedical Sciences, Endocrinology Research Section, University of Copenhagen, Copenhagen, Denmark</aff><aff id="I6"><label>6</label>Obesity and Metabolism Research Unit, USDA-ARS-Western Human Nutrition Research Center, Davis CA, USA</aff><aff id="I7"><label>7</label>Faculty of Nutrition, Texas A&#x00026;M University, College Station, TX, USA</aff><aff id="I8"><label>8</label>K.G. Jebsen Center of Exercise in Medicine at Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway</aff><aff id="I9"><label>9</label>Department of Internal Medicine, Amager University Hospital, Copenhagen, Denmark</aff><aff id="I10"><label>10</label>Clinical Research Centre, Hvidovre University Hospital, Copenhagen, Denmark</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>19</day><month>11</month><year>2013</year></pub-date><volume>13</volume><fpage>106</fpage><lpage>106</lpage><history><date date-type="received"><day>18</day><month>10</month><year>2013</year></date><date date-type="accepted"><day>11</day><month>11</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Pedersen et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Pedersen et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2261/13/106"/><abstract><sec><title>Background</title><p>Coronary artery disease (CAD) is accountable for more than 7 million deaths each year according to the World Health Organization (WHO). In a European population 80% of patients diagnosed with CAD are overweight and 31% are obese. Physical inactivity and overweight are major risk factors in CAD, thus central strategies in secondary prevention are increased physical activity and weight loss.</p></sec><sec><title>Methods/Design</title><p>In a randomized controlled trial 70 participants with stable CAD, age 45&#x02013;75, body mass index 28&#x02013;40&#x000a0;kg/m<sup>2</sup> and no diabetes are randomized (1:1) to 12&#x000a0;weeks of intensive exercise or weight loss both succeeded by a 40-week follow-up. The exercise protocol consist of supervised aerobic interval training (AIT) at 85-90% of VO<sub>2</sub>peak 3 times weekly for 12&#x000a0;weeks followed by supervised AIT twice weekly for 40&#x000a0;weeks. In the weight loss arm dieticians instruct the participants in a low energy diet (800&#x02013;1000&#x000a0;kcal/day) for 12&#x000a0;weeks, followed by 40&#x000a0;weeks of weight maintenance combined with supervised AIT twice weekly. The primary endpoint of the study is change in coronary flow reserve after the first 12&#x000a0;weeks&#x02019; intervention. Secondary endpoints include cardiovascular, metabolic, inflammatory and anthropometric measures.</p></sec><sec><title>Discussion</title><p>The study will compare the short and long-term effects of a protocol consisting of AIT alone or a rapid weight loss followed by AIT. Additionally, it will provide new insight in mechanisms behind the benefits of exercise and weight loss. We wish to contribute to the creation of effective secondary prevention and sustainable rehabilitation strategies in the large population of overweight and obese patients diagnosed with CAD.</p></sec><sec><title>Trial registration</title><p>ClinicalTrials.gov:
<ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/ct2/show/NCT01724567?term=CUT+IT&#x00026;rank=1">NCT01724567</ext-link></p></sec></abstract><kwd-group><kwd>Coronary artery disease</kwd><kwd>Secondary prevention</kwd><kwd>Rehabilitation</kwd><kwd>Exercise</kwd><kwd>Overweight</kwd><kwd>Obesity</kwd><kwd>Weight loss</kwd><kwd>Life style changes</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Coronary artery disease (CAD) is accountable for more than 7 million deaths each year according to the World Health Organization (WHO)
[<xref ref-type="bibr" rid="B1">1</xref>]. Overweight and physical inactivity are major risk factors in CAD. Weight loss through reduced calorie intake and improved fitness through increased physical activity are central strategies in both primary and secondary prevention. CAD mortality has decreased considerably during the last 30&#x000a0;years due to improved treatment, prevention and rehabilitation
[<xref ref-type="bibr" rid="B2">2</xref>]. However, due to the increased life expectancy the prevalence of CAD is increasing; thus, effective secondary prevention, optimal patient advice and sustainable rehabilitation programs are essential in decreasing morbidity and increasing quality of life in CAD.</p><sec><title>Benefits of exercise training on cardiovascular risk factors</title><p>Peak aerobic capacity (VO<sub>2</sub>peak) is a predictor of all-cause mortality in patients with CAD
[<xref ref-type="bibr" rid="B3">3</xref>]. Several smaller studies in patients with metabolic syndrome
[<xref ref-type="bibr" rid="B4">4</xref>], CAD
[<xref ref-type="bibr" rid="B5">5</xref>], congestive heart failure (CHF)
[<xref ref-type="bibr" rid="B6">6</xref>], hypertension
[<xref ref-type="bibr" rid="B7">7</xref>] and diabetes
[<xref ref-type="bibr" rid="B8">8</xref>] have shown that aerobic interval training (AIT) is superior to moderate continuous training in improving VO<sub>2</sub>peak and other cardiovascular risk markers such as endothelial function, glucose tolerance, hypertension and dyslipidemia. Furthermore, longer-term exercise training may even be superior to percutaneous coronary intervention (PCI) with stent implantation on event-free survival, anti-inflammatory effect and cost-effectiveness in selected patients with stable CAD
[<xref ref-type="bibr" rid="B9">9</xref>].</p></sec><sec><title>Benefits of weight loss on cardiovascular risk factors</title><p>Obesity is a modifiable, independent risk factor of cardiovascular disease
[<xref ref-type="bibr" rid="B10">10</xref>]. In a European population 80% of the patients diagnosed with CAD are overweight (Body Mass Index (BMI)&#x02009;&#x0003e;&#x02009;25&#x000a0;kg/m<sup>2</sup>) and 31% are obese (BMI&#x02009;&#x0003e;&#x02009;30&#x000a0;kg/m<sup>2</sup>)
[<xref ref-type="bibr" rid="B11">11</xref>]. In overweight but otherwise healthy subjects, a low energy diet (LED), defined as 800 &#x02013; 1000&#x000a0;kcal/day, resulted in a considerable weight loss with no apparent risk
[<xref ref-type="bibr" rid="B12">12</xref>]; however, there are no studies describing the use of LED in patients with CAD. The pan-European study DiOGenes used an LED to facilitate an initial weight loss of more than 8% of the original body weight in an overweight population, which resulted in a reduction of both cardiovascular
[<xref ref-type="bibr" rid="B13">13</xref>] and metabolic risk
[<xref ref-type="bibr" rid="B14">14</xref>]. A British study using a very low energy diet (600&#x000a0;kcal) to induce weight loss showed that insulin resistance and beta cell failure could be reversed in diabetic patients
[<xref ref-type="bibr" rid="B15">15</xref>]. Reduced heart rate variability (HRV) is an established marker of cardiovascular risk. In the COBRA study
[<xref ref-type="bibr" rid="B16">16</xref>], a 5% weight loss in postmenopausal obese women led to an increase in HRV.</p><p>A considerable challenge is to maintain a stable weight following the initial weight loss. According to the DiOGenes study, the most effective way to achieve this is ad libitum consumption of a diet with high protein content and low glycemic index carbohydrates
[<xref ref-type="bibr" rid="B17">17</xref>]. The effect of this diet prescription in CAD patients is not well described; however, the participants in the DiOGenes study obtained reductions in triglycerides and high sensitivity C-reactive protein (hsCRP) while HDL cholesterol was significantly increased after 26&#x000a0;weeks&#x02019; diet
[<xref ref-type="bibr" rid="B13">13</xref>].</p></sec><sec><title>The effect of lifestyle changes</title><p>Large interventional studies aiming at weight reduction and improved fitness in overweight subjects have found a favorable effect on cardiometabolic risk following intervention
[<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. The recent look AHEAD trial showed improved fitness and glycemic control and a reduction in weight and cardiovascular risk factors in overweight patients with type II diabetes undergoing lifestyle intervention compared with diabetes support and education after one
[<xref ref-type="bibr" rid="B20">20</xref>] and four
[<xref ref-type="bibr" rid="B21">21</xref>] years&#x02019; intervention. Nonetheless, improvements were difficult to sustain over a prolonged period and there was no difference in cardiovascular morbidity and mortality after a median follow-up of 9.6&#x000a0;years
[<xref ref-type="bibr" rid="B22">22</xref>]. A Danish study from 2012 comparing endurance training with or without weight loss and weight loss obtained by calorie restriction in sedentary, moderately overweight but otherwise healthy young men found that loss of fat mass improved hepatic insulin sensitivity, while peripheral insulin sensitivity and VO<sub>2</sub>peak were improved only by endurance training
[<xref ref-type="bibr" rid="B23">23</xref>].</p></sec><sec><title>Coronary flow reserve, weight loss and exercise</title><p>Coronary flow reserve (CFR), which is a measure of coronary microvascular function in the absence of significant stenosis, is reduced in individuals with diabetes
[<xref ref-type="bibr" rid="B24">24</xref>], obesity
[<xref ref-type="bibr" rid="B25">25</xref>] and CAD
[<xref ref-type="bibr" rid="B26">26</xref>]. CFR has been shown to be a predictor of poor prognosis and mortality in patients with known or suspected CAD even when the coronary arteries were normal
[<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. In CHF patients CFR has been shown to be positively correlated to VO<sub>2</sub>peak
[<xref ref-type="bibr" rid="B29">29</xref>]. Exercise training has been shown to improve CFR in patients with CAD
[<xref ref-type="bibr" rid="B30">30</xref>], while weight reduction following a multidisciplinary rehabilitation program resulted in improved CFR in overweight persons with no CAD
[<xref ref-type="bibr" rid="B25">25</xref>]. To our knowledge, there are no interventional studies in CAD patients comparing the effect of weight loss and exercise on CFR.</p></sec><sec><title>Weight loss, exercise and insulin resistance</title><p>Insulin resistance is directly associated to CAD
[<xref ref-type="bibr" rid="B31">31</xref>]. Physical exercise and weight loss have been shown to improve insulin action
[<xref ref-type="bibr" rid="B19">19</xref>], which is considered an important mechanism behind the reduction in cardiovascular risk in CAD with lifestyle modification. Presence of abdominal adipose tissue particularly is associated with insulin resistance and thus cardiovascular risk via pathways involving adipokines, cytokines, ceramides and dysfunctional fatty acid composition
[<xref ref-type="bibr" rid="B32">32</xref>].</p><p>Incretin hormones, released from the small intestine, play an important role in insulin secretion and resistance. Incretin secretion is impaired in patients with diabetes and smaller reductions in secretion are seen in overweight and obese individuals with insulin resistance and impaired glucose tolerance
[<xref ref-type="bibr" rid="B33">33</xref>]. Incretin hormones facilitate the glucose uptake in the myocardium and are possibly associated with left ventricular function in CAD
[<xref ref-type="bibr" rid="B34">34</xref>]. This could imply that changes in incretin function in overweight individuals following weight loss play a role in changes in cardiac and endothelial function. Small studies have indicated that physical exercise could influence incretin secretion
[<xref ref-type="bibr" rid="B35">35</xref>], however, knowledge is limited regarding the effect of exercise and weight loss on incretin function as well as the metabolic and hormonal effect in adipose tissue.</p></sec><sec><title>Rationale of the study</title><p>Several benefits from weight loss and exercise training on cardiovascular and diabetes risk factors have been described. Both LED and AIT could be first choice in secondary prevention in patients with CAD, yet a head-to-head comparison has not yet been performed. Thus, the primary objective of the CUT IT study is to investigate the effect of an effective weight loss protocol compared to 12&#x000a0;weeks of intensive AIT in overweight CAD patients. The primary endpoint is change in CFR and secondary endpoints describe the effect of the intervention on cardiovascular, metabolic and inflammatory risk markers. Secondary objectives are sustainability of the results during a 40-week follow-up period, containing AIT twice weekly or weight maintenance and AIT twice weekly.</p></sec></sec><sec><title>Methods/Design</title><sec><title>Study population</title><p>Participants were included in the study from September 2011 to April 2013. The study is on-going and the last participants will be evaluated in April 2014. We included 70 patients (Figure&#x000a0;
<xref ref-type="fig" rid="F1">1</xref>) with stable CAD; age 45&#x02013;75&#x000a0;years, BMI 28&#x02013;40&#x000a0;kg/m<sup>2</sup> not diagnosed with diabetes. Further inclusion and exclusion criteria are listed in Table&#x000a0;
<xref ref-type="table" rid="T1">1</xref>. The participants were found through the coronary rehabilitation unit at Bispebjerg University Hospital and a registry of coronary angiography, which comprises all angiographies performed in the Danish Capital Region. If the medical record did not reveal any exclusion criteria, a letter of invitation was sent with written information about the trial. People interested in participation were invited to a screening visit, conducted by a medical doctor connected to the study, where they received information about the study orally. To screen for certain exclusion criteria echocardiography and cardiopulmonary exercise test (CPET) including ECG were performed. Furthermore, blood samples were taken to screen for diabetes, kidney- and liver disease. If eligible and still interested the participant signed informed consent.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Study design and inclusion.</p></caption><graphic xlink:href="1471-2261-13-106-1"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Inclusion and exclusion criteria</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/></colgroup><tbody><tr><td rowspan="3" align="left" valign="top">Inclusion criteria<hr/></td><td align="left" valign="bottom">Stable CAD (defined as previous MI, PCI, CABG&#x02009;&#x0003e;&#x02009;6&#x000a0;months prior to inclusion or classic angina pectoris and positive angiogram/SPECT/CT-angiogram)<hr/></td></tr><tr><td align="left" valign="bottom">Age 45&#x02013;75&#x000a0;years<hr/></td></tr><tr><td align="left" valign="bottom">BMI 28&#x02013;40&#x000a0;kg/m<sup>2</sup><hr/></td></tr><tr><td rowspan="13" align="left" valign="top">Exclusion criteria</td><td align="left" valign="bottom">Known diabetes<hr/></td></tr><tr><td align="left" valign="bottom">Diabetes diagnosed at screening (repeated fasting plasma glucose&#x02009;&#x02265;&#x02009;7&#x000a0;mM or Hba1c&#x02009;&#x0003e;&#x02009;7%)<hr/></td></tr><tr><td align="left" valign="bottom">Severe or moderate valve disease<hr/></td></tr><tr><td align="left" valign="bottom">Main stem stenosis<hr/></td></tr><tr><td align="left" valign="bottom">Ejection Fraction &#x0003c;&#x02009;35%<hr/></td></tr><tr><td align="left" valign="bottom">Physical or mental disability - expected to prevent completion of intervention<hr/></td></tr><tr><td align="left" valign="bottom">Severe COPD or asthma (FEV1&#x02009;&#x0003c;&#x02009;50% of expected)<hr/></td></tr><tr><td align="left" valign="bottom">Active cancer<hr/></td></tr><tr><td align="left" valign="bottom">Severe kidney (eGFR&#x02009;&#x0003c;&#x02009;40&#x000a0;mL/hour) or severe liver disease<hr/></td></tr><tr><td align="left" valign="bottom">Severe ischemia or arrhythmias during exercise test<hr/></td></tr><tr><td align="left" valign="bottom">2. or 3. degree AV block, not protected by pacemaker<hr/></td></tr><tr><td align="left" valign="bottom">Organised training more than 2 times a week prior to inclusion<hr/></td></tr><tr><td align="left">Significant weight loss or weight gain (&#x0003e;&#x02009;5%) 3&#x000a0;month prior to inclusion</td></tr></tbody></table><table-wrap-foot><p><italic>Abbreviations</italic>: <italic>BMI</italic> Body Mass Index, <italic>CAD</italic> Coronary Artery Disease, <italic>COPD</italic> Chronic Obstructive Pulmonary Disease, <italic>FEV1</italic> Forced Expiratory Volume the 1st second, <italic>eGFR</italic> estimated glomerular Filtration Rate, <italic>MI</italic> Myocardial Infarction, <italic>PCI</italic> Percutaneous Coronary Intervention, <italic>CABG</italic> Coronary Artery Bypass Graft.</p></table-wrap-foot></table-wrap></sec><sec><title>Randomization and stratification</title><p>The participants were consecutively enrolled during the inclusion period and randomized (1:1) into two groups:</p><p>(1) 12&#x000a0;weeks of AIT three times a week, followed by 40&#x000a0;weeks&#x02019; AIT twice weekly.</p><p>(2) 8&#x02013;10&#x000a0;weeks&#x02019; LED followed by 2&#x02013;4&#x000a0;weeks of transition to a high protein/low glycemic index diet and 40&#x000a0;weeks of weight loss maintenance and AIT twice weekly.</p><p>Randomization was stratified according to BMI (&#x02264; 32.5; &#x0003e; 32.5). A third party unrelated to the study performed en bloc randomization with bloc size 2, 4 and 6 using Stata 11.1 software (StataCorp, 4905 Lakeway Drive, College Station, TX, USA).</p></sec><sec><title>Intervention</title><sec><title>Aerobic interval training</title><p>The patients warm up at a moderate intensity for 10&#x000a0;minutes on a staircase (total of 73 steps, minimum 5 times up and down) or on an exercise bike, followed by high intensity interval training (85&#x02013;90% of VO<sub>2</sub>peak as determined by CPET, Borg scale 17&#x02013;18) on an exercise bike. The intervals are 1&#x02013;4&#x000a0;minutes, with a total of 16&#x000a0;minutes, separated by active pauses of 1&#x02013;3&#x000a0;minutes. The total duration of each training session is 38&#x000a0;minutes. Physiotherapists with experience in cardiac rehabilitation instruct the participants and supervise all training session. Training intensity is monitored using heart rate monitors, lactate measurements and the Borg Scale.</p></sec><sec><title>Low energy diet</title><p>The participants are instructed by experienced clinical dieticians to maintain an LED for 8&#x02013;10&#x000a0;weeks. The LED consisted of soups, shakes, porridge and bars from the Cambridge Weight Plan (Northants, UK) 4 times a day, combined with a few additional vegetables, yoghurt and one litre of skimmed milk resulting in a total of 800&#x02013;1000&#x000a0;kcal/day. The diet is designed to provide the participants with all necessary micro- and macronutrients and has previously been shown to be efficient in weight loss
[<xref ref-type="bibr" rid="B36">36</xref>]. The consultations with the dieticians are both individual and group sessions at study week 1, 2, 4, 6, 8 and 10. At study week 8 or 10 the participants are introduced to the maintenance diet.</p></sec><sec><title>Weight maintenance diet</title><p>The weight maintenance diet is a high protein/low glycemic index diet modified from the DiOGenes study
[<xref ref-type="bibr" rid="B17">17</xref>]. Taking into consideration that the participants have CAD the high protein diet was adapted to resemble the Mediterranean diet, which is recommended to heart patients
[<xref ref-type="bibr" rid="B2">2</xref>], thus the protein sources were mainly fish, poultry, egg, dairy, and vegetables. The transition to the maintenance diet is conducted during visits at week 8, 10 and 12 and hereafter the participants consult the dietician monthly.</p></sec></sec><sec><title>Baseline and follow-up examinations</title><p>All participants are examined at baseline, after 12&#x000a0;weeks and after a year (flowchart summarized in Figure&#x000a0;
<xref ref-type="fig" rid="F1">1</xref>). Most examinations were performed at University Hospital of Bispebjerg, Department of Cardiology, except the MRI that was performed at University Hospital of Herlev and PET that was performed at Rigshospitalet. The primary endpoint is change in CFR following the first 12-weeks&#x02019; intervention. Coronary flow velocity (CFV) is measured using transthoracic Doppler echocardiography to determine the flow in the distal part of the left anterior descending (LAD) coronary artery. CFR is calculated as the ratio between CFV at rest and during hyperaemia induced by infusion of dipyridamole or adenosine. Cardiac positron emission tomography-computed tomography (PET/CT) is used as the &#x0201c;gold standard&#x0201d; to validate CFR in a sample of the population.</p><p>Secondary endpoints will provide cardiovascular and metabolic insight into the effects of exercise and weight loss:</p><sec><title>Cardiovascular endpoints</title><p>&#x02022; Aerobic exercise capacity assessed by VO<sub>2</sub>peak</p><p>&#x02022; Systolic and diastolic function assessed by echocardiography at rest and during semi-supine exercise</p><p>&#x02022; Heart rate variability and ischaemic burden assessed by 48&#x000a0;hours Holter monitoring</p><p>&#x02022; Peripheral endothelial function assessed digitally using the Endopat2000
[<xref ref-type="bibr" rid="B37">37</xref>]</p><p>&#x02022; Blood pressure</p></sec><sec><title>Metabolic and inflammatory endpoints</title><p>&#x02022; Beta cell function, insulin production and response expressed as Matsuda-index
[<xref ref-type="bibr" rid="B8">8</xref>] and HOMA-index and assessed using a 3-hour oral glucose tolerance test (OGTT)</p><p>&#x02022; Incretin hormone response measured during a 3-hour OGTT</p><p>&#x02022; Non-esterified fatty acids response measured during the 3-hour OGTT</p><p>&#x02022; Inflammatory markers: interleukin-6 (IL-6), tumour necrosis factor alpha (TNF-&#x003b1;), high sensitive C-reactive protein (hsCRP) and soluble urokinase plasminogen activating receptor (suPAR)</p><p>&#x02022; Fasting triglycerides and lipoproteins</p><p>&#x02022; Oxidized lipids, lipoprotein particle size and density distribution</p><p>&#x02022; Adipokines</p><p>&#x02022; Body composition assessed by anthropometry and dual X-ray absorptiometry (DEXA)</p><p>&#x02022; Visceral, liver and ectopic muscle fat assessed by abdominal magnetic resonance imaging (MRI)</p><p>&#x02022; Fatty acids composition, ceramides and cytokine mRNA expression in adipose tissue</p></sec><sec><title>Other parameters</title><p>&#x02022; Physical activity assessed by accelerometer and International Physical Activity Questionnaire (IPAQ)</p><p>&#x02022; Changes in diet assessed by a 3-day written diet record</p><p>&#x02022; Anxiety and depression symptoms assessed by the Hospital Anxiety and Depression (HADS) questionnaire</p></sec></sec><sec><title>Statistics</title><p>The primary endpoint was CFR and we wished to be able to detect difference in change in CFR between groups of 10%, equal to a change in CFR of 0.24 assuming a baseline mean CFR of 2.4 in similar patient groups from our experience
[<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. Information on the expected standard deviation (SD) of the within individual change was not available and was therefore conservatively assumed to be 0.3. With power of 0.8 and two-sided significance level of 0.05, 26 patients should be included in each group. Anticipating 30% dropout, randomization of a total of 70 patients was chosen. Based on previous studies, this sample size is sufficient to detect relevant differences in endothelial function
[<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>], HRV
[<xref ref-type="bibr" rid="B41">41</xref>], Matsuda index
[<xref ref-type="bibr" rid="B8">8</xref>] and HOMA
[<xref ref-type="bibr" rid="B42">42</xref>]. With a SD of CFR of 0.6, this sample size will provide 80% power to detect a between group difference of 0.5 in CFR after the intervention.</p><p>Analyses will be by intention-to-treat whenever possible and care will be taken to encourage drop-outs to participate in follow-up examinations.</p></sec><sec><title>Ethics and dissemination</title><p>The study complies with the Declaration of Helsinki and has been approved by the Regional Ethics Committee of the Capital Region in Denmark (no H-4-2012-146) and the Danish Data Protection Agency (no 2011-41-6313). Participants gave oral and written informed consent and are free to decline or retract participation at any time. All data are handled confidentially and the participants are ensured anonymity. The trial is registered at clinicaltrials.gov (NCT01724567). Our findings will be published in peer-reviewed journals and presented at national and international congresses.</p><p>Most of the procedures are used in everyday clinical practice and the side effects are temporary. The participants will experience some discomfort related to the adipose tissue biopsy and during infusion with dipyridamole/adenosine used to induce stress during the CFR assessment (echocardiography and PET/CT). The study will provide knowledge on the optimal composition of effective rehabilitation programs to help the large group of overweight patients with CAD. Furthermore, we expect each participant to benefit directly from the intervention independent of which study arm they are randomized to.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The CUT IT trial is a single-center, randomized, interventional trial with consecutive inclusion of participants. In- and exclusion criteria have been selected trying to balance the wish to have high external validity, yet without creating a population with too much heterogeneity. Randomization will limit selection bias. Monitoring with accelerometers, IPAQ and diet records are performed in order to assess if participants in the weight loss arm change their physical activity level and if the participants in the exercise arm change their diet during the intervention period. Concerning external validity we must also consider that people agreeing to participate in an intervention study, are more motivated to lifestyle changes than a general population of patients with CAD. Analysis of non-participants from registry data will assess the size of potential bias.</p><p>The primary endpoint is CFR assessed by transthoracic Doppler echocardiography. This non-invasive measure of CFR has been validated against invasive measurements
[<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>] and PET
[<xref ref-type="bibr" rid="B45">45</xref>]. CFR is performed at our research unit with a low intra- and inter-observer variability and good repeatability
[<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B46">46</xref>].</p><p>Blinding of participants and investigators is an important issue in clinical trials. In this study blinding of the participants to the intervention is not possible. Blinding of the investigator in examinations involving contact to the participants is difficult, since it is possible to distinguish the participants in the weight loss group from the ones in the exercise group, due to the expected weight loss. This is relevant concerning echocardiography and exercise testing. The same echo-cardiographer will perform all the examinations to prevent inter-observer variation and a person blinded to the intervention will perform the off-line echo analyses. In exercise testing we try to limit bias by using standardised written instructions for each test and to blind the investigator to the result of baseline test.</p><p>Biochemical analysis of adipose tissue and plasma samples and Holter analysis will be blinded to randomization. Performance and analysis of MRI and PET/CT-scan will be blinded to randomization. Endothelial function is calculated by the Endopat2000 software independently of the person performing the examination.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>We aim to undertake a head-to-head comparison of AIT along with rapid weight loss followed by AIT on cardiovascular risk markers and cardiac function in overweight patients with CAD. The study will, furthermore, provide important mechanistic insights of both short- and long-term effects of the two interventions. Importantly, the study will provide guidance on best rehabilitation strategies in the large number of overweight and obese patients suffering from CAD.</p></sec><sec><title>Competing interests</title><p>The Cambridge Weight Plan supplied the LED, but had no influence on the design of the study and will not have any influence on the analysis and interpretation of the results.</p></sec><sec><title>Authors&#x02019; contributions</title><p>LRP, RHO, EP and SH designed the study and drafted the manuscript. LRP and RHO are daily coordinators of the trial with supervision from EP and SH. The remaining co-authors contributed to the study design on the following subjects: MF and UW: exercise intervention; AA: diet intervention; EC: abdominal MRI; PH and AK; PET/CT; JJH, incretins; JN and RW, plasma lipoproteins and adipose tissue biopsies, AS: Holter monitoring. The manuscript was read, revised and finally approved by all co-authors.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2261/13/106/prepub">http://www.biomedcentral.com/1471-2261/13/106/prepub</ext-link></p></sec></body><back><sec><title>Acknowledgements</title><p>Bispebjerg University Hospital, The Danish Heart Foundation, The Danish Council for Independent Research (under The Danish Agency for Science, Technology and Innovation), The Faculty of Health and Medical Sciences, University of Copenhagen, The Beckett Foundation and Else and Mogens Wedell-Wedellborg&#x02019;s Foundation. The Cambridge Weight Plan (Northants, UK) supplied the LED.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="book"><person-group person-group-type="editor">Mendis S, Puska P, Norrving B</person-group><source>Global atlas on cardiovascular disease prevention and control</source><year>2011</year><publisher-name>Geneva: World Health Organization</publisher-name></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Perk</surname><given-names>J</given-names></name><name><surname>De</surname><given-names>BG</given-names></name><name><surname>Gohlke</surname><given-names>H</given-names></name><name><surname>Graham</surname><given-names>I</given-names></name><name><surname>Reiner</surname><given-names>Z</given-names></name><name><surname>Verschuren</surname><given-names>WM</given-names></name><etal/><article-title>European guidelines on cardiovascular disease prevention in clinical practice (Version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by Representatives of Nine Societies and by Invited Experts)</article-title><source>Int J Behav Med</source><year>2012</year><volume>19</volume><fpage>403</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1007/s12529-012-9242-5</pub-id><pub-id pub-id-type="pmid">23093473</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Keteyian</surname><given-names>SJ</given-names></name><name><surname>Brawner</surname><given-names>CA</given-names></name><name><surname>Savage</surname><given-names>PD</given-names></name><name><surname>Ehrman</surname><given-names>JK</given-names></name><name><surname>Schairer</surname><given-names>J</given-names></name><name><surname>Divine</surname><given-names>G</given-names></name><etal/><article-title>Peak aerobic capacity predicts prognosis in patients with coronary heart disease</article-title><source>Am Heart J</source><year>2008</year><volume>156</volume><fpage>292</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2008.03.017</pub-id><pub-id pub-id-type="pmid">18657659</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Tjonna</surname><given-names>AE</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Rognmo</surname><given-names>O</given-names></name><name><surname>Stolen</surname><given-names>TO</given-names></name><name><surname>Bye</surname><given-names>A</given-names></name><name><surname>Haram</surname><given-names>PM</given-names></name><etal/><article-title>Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study</article-title><source>Circulation</source><year>2008</year><volume>118</volume><fpage>346</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.772822</pub-id><pub-id pub-id-type="pmid">18606913</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Rognmo</surname><given-names>O</given-names></name><name><surname>Hetland</surname><given-names>E</given-names></name><name><surname>Helgerud</surname><given-names>J</given-names></name><name><surname>Hoff</surname><given-names>J</given-names></name><name><surname>Slordahl</surname><given-names>SA</given-names></name><article-title>High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2004</year><volume>11</volume><fpage>216</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1097/01.hjr.0000131677.96762.0c</pub-id><pub-id pub-id-type="pmid">15179103</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Wisloff</surname><given-names>U</given-names></name><name><surname>Stoylen</surname><given-names>A</given-names></name><name><surname>Loennechen</surname><given-names>JP</given-names></name><name><surname>Bruvold</surname><given-names>M</given-names></name><name><surname>Rognmo</surname><given-names>O</given-names></name><name><surname>Haram</surname><given-names>PM</given-names></name><etal/><article-title>Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study</article-title><source>Circulation</source><year>2007</year><volume>115</volume><fpage>3086</fpage><lpage>3094</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.675041</pub-id><pub-id pub-id-type="pmid">17548726</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Molmen-Hansen</surname><given-names>HE</given-names></name><name><surname>Stolen</surname><given-names>T</given-names></name><name><surname>Tjonna</surname><given-names>AE</given-names></name><name><surname>Aamot</surname><given-names>IL</given-names></name><name><surname>Ekeberg</surname><given-names>IS</given-names></name><name><surname>Tyldum</surname><given-names>GA</given-names></name><etal/><article-title>Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients</article-title><source>Eur J Prev Cardiol</source><year>2012</year><volume>19</volume><fpage>151</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1177/1741826711400512</pub-id><pub-id pub-id-type="pmid">21450580</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Eriksen</surname><given-names>L</given-names></name><name><surname>Hl-Petersen</surname><given-names>I</given-names></name><name><surname>Haugaard</surname><given-names>SB</given-names></name><name><surname>Dela</surname><given-names>F</given-names></name><article-title>Comparison of the effect of multiple short-duration with single long-duration exercise sessions on glucose homeostasis in type 2 diabetes mellitus</article-title><source>Diabetologia</source><year>2007</year><volume>50</volume><fpage>2245</fpage><lpage>2253</lpage><pub-id pub-id-type="doi">10.1007/s00125-007-0783-0</pub-id><pub-id pub-id-type="pmid">17763840</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Walther</surname><given-names>C</given-names></name><name><surname>Mobius-Winkler</surname><given-names>S</given-names></name><name><surname>Linke</surname><given-names>A</given-names></name><name><surname>Bruegel</surname><given-names>M</given-names></name><name><surname>Thiery</surname><given-names>J</given-names></name><name><surname>Schuler</surname><given-names>G</given-names></name><etal/><article-title>Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2008</year><volume>15</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1097/HJR.0b013e3282f29aa6</pub-id><pub-id pub-id-type="pmid">18277195</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Hubert</surname><given-names>HB</given-names></name><name><surname>Feinleib</surname><given-names>M</given-names></name><name><surname>McNamara</surname><given-names>PM</given-names></name><name><surname>Castelli</surname><given-names>WP</given-names></name><article-title>Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study</article-title><source>Circulation</source><year>1983</year><volume>67</volume><fpage>968</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.67.5.968</pub-id><pub-id pub-id-type="pmid">6219830</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>De</surname><given-names>BD</given-names></name><name><surname>De</surname><given-names>BG</given-names></name><name><surname>Cokkinos</surname><given-names>D</given-names></name><name><surname>Keil</surname><given-names>U</given-names></name><name><surname>Montaye</surname><given-names>M</given-names></name><name><surname>Ostor</surname><given-names>E</given-names></name><etal/><article-title>Overweight and obesity in patients with established coronary heart disease: are we meeting the challenge?</article-title><source>Eur Heart J</source><year>2004</year><volume>25</volume><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1016/j.ehj.2003.10.024</pub-id><pub-id pub-id-type="pmid">14720528</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Tsai</surname><given-names>AG</given-names></name><name><surname>Wadden</surname><given-names>TA</given-names></name><article-title>The evolution of very-low-calorie diets: an update and meta-analysis</article-title><source>Obesity (Silver Spring)</source><year>2006</year><volume>14</volume><fpage>1283</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1038/oby.2006.146</pub-id><pub-id pub-id-type="pmid">16988070</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Gogebakan</surname><given-names>O</given-names></name><name><surname>Kohl</surname><given-names>A</given-names></name><name><surname>Osterhoff</surname><given-names>MA</given-names></name><name><surname>van Baak</surname><given-names>MA</given-names></name><name><surname>Jebb</surname><given-names>SA</given-names></name><name><surname>Papadaki</surname><given-names>A</given-names></name><etal/><article-title>Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial</article-title><source>Circulation</source><year>2011</year><volume>124</volume><fpage>2829</fpage><lpage>2838</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.033274</pub-id><pub-id pub-id-type="pmid">22104550</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Goyenechea</surname><given-names>E</given-names></name><name><surname>Holst</surname><given-names>C</given-names></name><name><surname>Saris</surname><given-names>WH</given-names></name><name><surname>Jebb</surname><given-names>S</given-names></name><name><surname>Kafatos</surname><given-names>A</given-names></name><name><surname>Pfeiffer</surname><given-names>A</given-names></name><etal/><article-title>Effects of different protein content and glycemic index of ad libitum diets on diabetes risk factors in overweight adults: the DIOGenes multicentre, randomised, dietary intervention trial</article-title><source>Diabetes Metab Res Rev</source><year>2011</year><volume>27</volume><fpage>705</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1002/dmrr.1218</pub-id><pub-id pub-id-type="pmid">21591241</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Lim</surname><given-names>EL</given-names></name><name><surname>Hollingsworth</surname><given-names>KG</given-names></name><name><surname>Aribisala</surname><given-names>BS</given-names></name><name><surname>Chen</surname><given-names>MJ</given-names></name><name><surname>Mathers</surname><given-names>JC</given-names></name><name><surname>Taylor</surname><given-names>R</given-names></name><article-title>Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol</article-title><source>Diabetologia</source><year>2011</year><volume>54</volume><fpage>2506</fpage><lpage>2514</lpage><pub-id pub-id-type="doi">10.1007/s00125-011-2204-7</pub-id><pub-id pub-id-type="pmid">21656330</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="other"><name><surname>Mouridsen</surname><given-names>MR</given-names></name><name><surname>Bendsen</surname><given-names>NT</given-names></name><name><surname>Astrup</surname><given-names>A</given-names></name><name><surname>Haugaard</surname><given-names>SB</given-names></name><name><surname>Binici</surname><given-names>Z</given-names></name><name><surname>Sajadieh</surname><given-names>A</given-names></name><article-title>Modest weight loss in moderately overweight postmenopausal women improves heart rate variability</article-title><source>Eur J Prev Cardiol</source><year>2012</year></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Larsen</surname><given-names>TM</given-names></name><name><surname>Dalskov</surname><given-names>SM</given-names></name><name><surname>Van</surname><given-names>BM</given-names></name><name><surname>Jebb</surname><given-names>SA</given-names></name><name><surname>Papadaki</surname><given-names>A</given-names></name><name><surname>Pfeiffer</surname><given-names>AF</given-names></name><etal/><article-title>Diets with high or low protein content and glycemic index for weight-loss maintenance</article-title><source>N Engl J Med</source><year>2010</year><volume>363</volume><fpage>2102</fpage><lpage>2113</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1007137</pub-id><pub-id pub-id-type="pmid">21105792</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Lindstrom</surname><given-names>J</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Valle</surname><given-names>TT</given-names></name><name><surname>Hamalainen</surname><given-names>H</given-names></name><name><surname>Ilanne-Parikka</surname><given-names>P</given-names></name><etal/><article-title>Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance</article-title><source>N Engl J Med</source><year>2001</year><volume>344</volume><fpage>1343</fpage><lpage>1350</lpage><pub-id pub-id-type="doi">10.1056/NEJM200105033441801</pub-id><pub-id pub-id-type="pmid">11333990</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name><name><surname>Fowler</surname><given-names>SE</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Lachin</surname><given-names>JM</given-names></name><name><surname>Walker</surname><given-names>EA</given-names></name><etal/><article-title>Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><fpage>393</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">11832527</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Wing</surname><given-names>RR</given-names></name><name><surname>Lang</surname><given-names>W</given-names></name><name><surname>Wadden</surname><given-names>TA</given-names></name><name><surname>Safford</surname><given-names>M</given-names></name><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Bertoni</surname><given-names>AG</given-names></name><etal/><article-title>Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes</article-title><source>Diabetes Care</source><year>2011</year><volume>34</volume><fpage>1481</fpage><lpage>1486</lpage><pub-id pub-id-type="doi">10.2337/dc10-2415</pub-id><pub-id pub-id-type="pmid">21593294</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Wing</surname><given-names>RR</given-names></name><article-title>Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial</article-title><source>Arch Intern Med</source><year>2010</year><volume>170</volume><fpage>1566</fpage><lpage>1575</lpage><pub-id pub-id-type="pmid">20876408</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Wing</surname><given-names>RR</given-names></name><name><surname>Bolin</surname><given-names>P</given-names></name><name><surname>Brancati</surname><given-names>FL</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Clark</surname><given-names>JM</given-names></name><name><surname>Coday</surname><given-names>M</given-names></name><etal/><article-title>Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes</article-title><source>N Engl J Med</source><year>2013</year><volume>369</volume><fpage>145</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">23796131</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="book"><name><surname>Nordby</surname><given-names>P</given-names></name><name><surname>Auerbach</surname><given-names>PL</given-names></name><name><surname>Rosenkilde</surname><given-names>M</given-names></name><name><surname>Kristiansen</surname><given-names>L</given-names></name><name><surname>Thomasen</surname><given-names>JR</given-names></name><name><surname>Rygaard</surname><given-names>L</given-names></name><etal/><source>Endurance Training Per Se Increases Metabolic Health in Young</source><year>2012</year><publisher-name>Obesity (Silver Spring): Moderately Overweight Men</publisher-name></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Atar</surname><given-names>AI</given-names></name><name><surname>Altuner</surname><given-names>TK</given-names></name><name><surname>Bozbas</surname><given-names>H</given-names></name><name><surname>Korkmaz</surname><given-names>ME</given-names></name><article-title>Coronary flow reserve in patients with diabetes mellitus and prediabetes</article-title><source>Echocardiography</source><year>2012</year><volume>29</volume><fpage>634</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1111/j.1540-8175.2012.01668.x</pub-id><pub-id pub-id-type="pmid">22404292</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Coppola</surname><given-names>A</given-names></name><name><surname>Marfella</surname><given-names>R</given-names></name><name><surname>Coppola</surname><given-names>L</given-names></name><name><surname>Tagliamonte</surname><given-names>E</given-names></name><name><surname>Fontana</surname><given-names>D</given-names></name><name><surname>Liguori</surname><given-names>E</given-names></name><etal/><article-title>Effect of weight loss on coronary circulation and adiponectin levels in obese women</article-title><source>Int J Cardiol</source><year>2009</year><volume>134</volume><fpage>414</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2007.12.087</pub-id><pub-id pub-id-type="pmid">18378021</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Sicari</surname><given-names>R</given-names></name><name><surname>Rigo</surname><given-names>F</given-names></name><name><surname>Cortigiani</surname><given-names>L</given-names></name><name><surname>Gherardi</surname><given-names>S</given-names></name><name><surname>Galderisi</surname><given-names>M</given-names></name><name><surname>Picano</surname><given-names>E</given-names></name><article-title>Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries</article-title><source>Am J Cardiol</source><year>2009</year><volume>103</volume><fpage>626</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2008.10.033</pub-id><pub-id pub-id-type="pmid">19231324</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Cortigiani</surname><given-names>L</given-names></name><name><surname>Rigo</surname><given-names>F</given-names></name><name><surname>Gherardi</surname><given-names>S</given-names></name><name><surname>Bovenzi</surname><given-names>F</given-names></name><name><surname>Molinaro</surname><given-names>S</given-names></name><name><surname>Picano</surname><given-names>E</given-names></name><etal/><article-title>Coronary flow reserve during dipyridamole stress echocardiography predicts mortality</article-title><source>JACC Cardiovasc Imaging</source><year>2012</year><volume>5</volume><fpage>1079</fpage><lpage>1085</lpage><pub-id pub-id-type="doi">10.1016/j.jcmg.2012.08.007</pub-id><pub-id pub-id-type="pmid">23153906</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Cortigiani</surname><given-names>L</given-names></name><name><surname>Rigo</surname><given-names>F</given-names></name><name><surname>Gherardi</surname><given-names>S</given-names></name><name><surname>Bovenzi</surname><given-names>F</given-names></name><name><surname>Picano</surname><given-names>E</given-names></name><name><surname>Sicari</surname><given-names>R</given-names></name><article-title>Implication of the continuous prognostic spectrum of Doppler echocardiographic derived coronary flow reserve on left anterior descending artery</article-title><source>Am J Cardiol</source><year>2010</year><volume>105</volume><fpage>158</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2009.08.669</pub-id><pub-id pub-id-type="pmid">20102911</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Snoer</surname><given-names>M</given-names></name><name><surname>Monk-Hansen</surname><given-names>T</given-names></name><name><surname>Olsen</surname><given-names>RH</given-names></name><name><surname>Pedersen</surname><given-names>LR</given-names></name><name><surname>Nielsen</surname><given-names>OW</given-names></name><name><surname>Rasmusen</surname><given-names>H</given-names></name><etal/><article-title>Coronary flow reserve as a link between diastolic and systolic function and exercise capacity in heart failure</article-title><source>Eur Heart J Cardiovasc Imaging</source><year>2012</year><volume>14</volume><fpage>677</fpage><lpage>683</lpage><pub-id pub-id-type="pmid">23169759</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Hambrecht</surname><given-names>R</given-names></name><name><surname>Wolf</surname><given-names>A</given-names></name><name><surname>Gielen</surname><given-names>S</given-names></name><name><surname>Linke</surname><given-names>A</given-names></name><name><surname>Hofer</surname><given-names>J</given-names></name><name><surname>Erbs</surname><given-names>S</given-names></name><etal/><article-title>Effect of exercise on coronary endothelial function in patients with coronary artery disease</article-title><source>N Engl J Med</source><year>2000</year><volume>342</volume><fpage>454</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1056/NEJM200002173420702</pub-id><pub-id pub-id-type="pmid">10675425</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Jeppesen</surname><given-names>J</given-names></name><name><surname>Hansen</surname><given-names>TW</given-names></name><name><surname>Rasmussen</surname><given-names>S</given-names></name><name><surname>Ibsen</surname><given-names>H</given-names></name><name><surname>Torp-Pedersen</surname><given-names>C</given-names></name><name><surname>Madsbad</surname><given-names>S</given-names></name><article-title>Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study</article-title><source>J Am Coll Cardiol</source><year>2007</year><volume>49</volume><fpage>2112</fpage><lpage>2119</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2007.01.088</pub-id><pub-id pub-id-type="pmid">17531661</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Summers</surname><given-names>SA</given-names></name><article-title>Ceramides in insulin resistance and lipotoxicity</article-title><source>Prog Lipid Res</source><year>2006</year><volume>45</volume><fpage>42</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.plipres.2005.11.002</pub-id><pub-id pub-id-type="pmid">16445986</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Holst</surname><given-names>JJ</given-names></name><article-title>The physiology of glucagon-like peptide 1</article-title><source>Physiol Rev</source><year>2007</year><volume>87</volume><fpage>1409</fpage><lpage>1439</lpage><pub-id pub-id-type="doi">10.1152/physrev.00034.2006</pub-id><pub-id pub-id-type="pmid">17928588</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Read</surname><given-names>PA</given-names></name><name><surname>Khan</surname><given-names>FZ</given-names></name><name><surname>Heck</surname><given-names>PM</given-names></name><name><surname>Hoole</surname><given-names>SP</given-names></name><name><surname>Dutka</surname><given-names>DP</given-names></name><article-title>DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease</article-title><source>Circ Cardiovasc Imaging</source><year>2010</year><volume>3</volume><fpage>195</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1161/CIRCIMAGING.109.899377</pub-id><pub-id pub-id-type="pmid">20075143</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Kelly</surname><given-names>KR</given-names></name><name><surname>Brooks</surname><given-names>LM</given-names></name><name><surname>Solomon</surname><given-names>TP</given-names></name><name><surname>Kashyap</surname><given-names>SR</given-names></name><name><surname>O'Leary</surname><given-names>VB</given-names></name><name><surname>Kirwan</surname><given-names>JP</given-names></name><article-title>The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity</article-title><source>Am J Physiol Endocrinol Metab</source><year>2009</year><volume>296</volume><fpage>E1269</fpage><lpage>E1274</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00112.2009</pub-id><pub-id pub-id-type="pmid">19351807</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Riecke</surname><given-names>BF</given-names></name><name><surname>Christensen</surname><given-names>R</given-names></name><name><surname>Christensen</surname><given-names>P</given-names></name><name><surname>Leeds</surname><given-names>AR</given-names></name><name><surname>Boesen</surname><given-names>M</given-names></name><name><surname>Lohmander</surname><given-names>LS</given-names></name><etal/><article-title>Comparing two low-energy diets for the treatment of knee osteoarthritis symptoms in obese patients: a pragmatic randomized clinical trial</article-title><source>Osteoarthritis Cartilage</source><year>2010</year><volume>18</volume><fpage>746</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2010.02.012</pub-id><pub-id pub-id-type="pmid">20206314</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Hamburg</surname><given-names>NM</given-names></name><name><surname>Keyes</surname><given-names>MJ</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Vasan</surname><given-names>RS</given-names></name><name><surname>Schnabel</surname><given-names>R</given-names></name><name><surname>Pryde</surname><given-names>MM</given-names></name><etal/><article-title>Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study</article-title><source>Circulation</source><year>2008</year><volume>117</volume><fpage>2467</fpage><lpage>2474</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.748574</pub-id><pub-id pub-id-type="pmid">18458169</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Logstrup</surname><given-names>BB</given-names></name><name><surname>Hofsten</surname><given-names>DE</given-names></name><name><surname>Christophersen</surname><given-names>TB</given-names></name><name><surname>Moller</surname><given-names>JE</given-names></name><name><surname>Botker</surname><given-names>HE</given-names></name><name><surname>Pellikka</surname><given-names>PA</given-names></name><etal/><article-title>Influence of abnormal glucose metabolism on coronary microvascular function after a recent myocardial infarction</article-title><source>JACC Cardiovasc Imaging</source><year>2009</year><volume>2</volume><fpage>1159</fpage><lpage>1166</lpage><pub-id pub-id-type="doi">10.1016/j.jcmg.2009.06.012</pub-id><pub-id pub-id-type="pmid">19833304</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Bonetti</surname><given-names>PO</given-names></name><name><surname>Barsness</surname><given-names>GW</given-names></name><name><surname>Keelan</surname><given-names>PC</given-names></name><name><surname>Schnell</surname><given-names>TI</given-names></name><name><surname>Pumper</surname><given-names>GM</given-names></name><name><surname>Kuvin</surname><given-names>JT</given-names></name><etal/><article-title>Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease</article-title><source>J Am Coll Cardiol</source><year>2003</year><volume>41</volume><fpage>1761</fpage><lpage>1768</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(03)00329-2</pub-id><pub-id pub-id-type="pmid">12767662</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Bonetti</surname><given-names>PO</given-names></name><name><surname>Pumper</surname><given-names>GM</given-names></name><name><surname>Higano</surname><given-names>ST</given-names></name><name><surname>Holmes</surname><given-names>DR</given-names><suffix>Jr</suffix></name><name><surname>Kuvin</surname><given-names>JT</given-names></name><name><surname>Lerman</surname><given-names>A</given-names></name><article-title>Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia</article-title><source>J Am Coll Cardiol</source><year>2004</year><volume>44</volume><fpage>2137</fpage><lpage>2141</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2004.08.062</pub-id><pub-id pub-id-type="pmid">15582310</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Akehi</surname><given-names>Y</given-names></name><name><surname>Yoshimatsu</surname><given-names>H</given-names></name><name><surname>Kurokawa</surname><given-names>M</given-names></name><name><surname>Sakata</surname><given-names>T</given-names></name><name><surname>Eto</surname><given-names>H</given-names></name><name><surname>Ito</surname><given-names>S</given-names></name><etal/><article-title>VLCD-induced weight loss improves heart rate variability in moderately obese Japanese</article-title><source>Exp Biol Med (Maywood )</source><year>2001</year><volume>226</volume><fpage>440</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">11393172</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Haugaard</surname><given-names>SB</given-names></name><name><surname>Vaag</surname><given-names>A</given-names></name><name><surname>Hoy</surname><given-names>CE</given-names></name><name><surname>Madsbad</surname><given-names>S</given-names></name><article-title>Desaturation of skeletal muscle structural and depot lipids in obese individuals during a very-low-calorie diet intervention</article-title><source>Obesity (Silver Spring)</source><year>2007</year><volume>15</volume><fpage>117</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1038/oby.2007.508</pub-id><pub-id pub-id-type="pmid">17228039</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Hozumi</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Akasaka</surname><given-names>T</given-names></name><name><surname>Asami</surname><given-names>Y</given-names></name><name><surname>Ogata</surname><given-names>Y</given-names></name><name><surname>Takagi</surname><given-names>T</given-names></name><etal/><article-title>Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique</article-title><source>J Am Coll Cardiol</source><year>1998</year><volume>32</volume><fpage>1251</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(98)00389-1</pub-id><pub-id pub-id-type="pmid">9809933</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Caiati</surname><given-names>C</given-names></name><name><surname>Montaldo</surname><given-names>C</given-names></name><name><surname>Zedda</surname><given-names>N</given-names></name><name><surname>Montisci</surname><given-names>R</given-names></name><name><surname>Ruscazio</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>G</given-names></name><etal/><article-title>Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve: comparison with intracoronary Doppler flow wire</article-title><source>J Am Coll Cardiol</source><year>1999</year><volume>34</volume><fpage>1193</fpage><lpage>1200</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(99)00342-3</pub-id><pub-id pub-id-type="pmid">10520812</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Saraste</surname><given-names>M</given-names></name><name><surname>Koskenvuo</surname><given-names>J</given-names></name><name><surname>Knuuti</surname><given-names>J</given-names></name><name><surname>Toikka</surname><given-names>J</given-names></name><name><surname>Laine</surname><given-names>H</given-names></name><name><surname>Niemi</surname><given-names>P</given-names></name><etal/><article-title>Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography</article-title><source>Clin Physiol</source><year>2001</year><volume>21</volume><fpage>114</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2281.2001.00296.x</pub-id><pub-id pub-id-type="pmid">11168305</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Snoer</surname><given-names>M</given-names></name><name><surname>Monk-Hansen</surname><given-names>T</given-names></name><name><surname>Olsen</surname><given-names>RH</given-names></name><name><surname>Pedersen</surname><given-names>LR</given-names></name><name><surname>Simonsen</surname><given-names>L</given-names></name><name><surname>Rasmusen</surname><given-names>H</given-names></name><etal/><article-title>Insulin resistance and exercise tolerance in heart failure patients: linkage to coronary flow reserve and peripheral vascular function</article-title><source>Cardiovasc Diabetol</source><year>2012</year><volume>11</volume><fpage>97</fpage><pub-id pub-id-type="doi">10.1186/1475-2840-11-97</pub-id><pub-id pub-id-type="pmid">22889317</pub-id></mixed-citation></ref></ref-list></back></article>